Human rpL3 induces G1/S arrest or apoptosis by modulating p21waf1/cip1 levels in a p53-independent manner

Cell Cycle

Volumn 12, Issue 1, 2013, Pages 76-87

  Russo, Annapina ^a,b   Esposito, Davide ^a   Catillo, Morena ^a   Pietropaolo, Concetta ^a   Crescenzi, Elvira ^c   Russo, Giulia ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^c CNR   (Italy)

Author keywords

Apoptosis; Cell cycle; Extraribosomal function; p21; Ribosomal protein; RpL3; SP1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROTEIN P53; R PROTEIN L3; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MITOCHONDRION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

EID: 84872292560     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.22963     Document Type: Article

References (47)

1. Jung YS, Qian Y, Chen X. Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal 2010; 22:1003-12; PMID:20100570; http://dx.doi.org/10.1016/j.cellsig.2010.01.013.
2. Chang LJ, Eastman A. Decreased translation of p21waf1 mRNA causes attenuated p53 signaling in some p53 wild-type tumors. Cell Cycle 2012; 11:1818-26; PMID:22510560; http://dx.doi.org/10.4161/cc.20208.
3. Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 2009; 9:400-14; PMID:19440234; http://dx.doi.org/10. 1038/nrc2657.
4. Tsao YP, Huang SJ, Chang JL, Hsieh JT, Pong RC, Chen SL. Adenovirus-mediated p21((WAF1/SDII/CIP1)) gene transfer induces apoptosis of human cervical cancer cell lines. J Virol 1999; 73:4983-90; PMID:10233960.
5. Yang HL, Pan JX, Sun L, Yeung SC. p21 Waf-1 (Cip-1) enhances apoptosis induced by manumycin and paclitaxel in anaplastic thyroid cancer cells. J Clin Endocrinol Metab 2003; 88:763-72; PMID:12574211; http://dx.doi.org/10.1210/jc. 2002-020992.
6. Kraljevic Pavelic S, Cacev T, Kralj M. A dual role of p21waf1/cip1 gene in apoptosis of HEp-2 treated with cisplatin or methotrexate. Cancer Gene Ther 2008; 15:576-90; PMID:18483502; http://dx.doi.org/10.1038/cgt.2008.28.
7. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, et al. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 1995; 9:935-44; PMID:7774811; http://dx.doi.org/10.1101/gad.9.8.935.
8. Koutsodontis G, Moustakas A, Kardassis D. The role of Sp1 family members, the proximal GC-rich motifs, and the upstream enhancer region in the regulation of the human cell cycle inhibitor p21WAF-1/Cip1 gene promoter. Biochemistry 2002; 41:12771-84; PMID:12379120; http://dx.doi.org/10.1021/bi026141q.
9. Wu J, Lingrel JB. KLF2 inhibits Jurkat T leukemia cell growth via upregulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1. Oncogene 2004; 23:8088-96; PMID:15361832; http://dx.doi.org/10.1038/sj.onc.1207996.
10. Gartel AL, Ye X, Goufman E, Shianov P, Hay N, Najmabadi F, et al. Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proc Natl Acad Sci USA 2001; 98:4510-5; PMID:11274368; http://dx.doi.org/10.1073/pnas. 081074898.
11. Koutsodontis G, Kardassis D. Inhibition of p53-mediated transcriptional responses by mithramycin A. Oncogene 2004; 23:9190-200; PMID:15489892.
12. Chew YC, Adhikary G, Wilson GM, Xu W, Eckert RL. Sulforaphane induction of p21(Cip1) cyclin-dependent kinase inhibitor expression requires p53 and Sp1 transcription factors and is p53-dependent. J Biol Chem 2012; 287:16168-78; PMID:22427654; http://dx.doi.org/10.1074/jbc.M111.305292.
13. Kondoh N, Shuda M, Tanaka K, Wakatsuki T, Hada A, Yamamoto M. Enhanced expression of S8, L12, L23a, L27 and L30 ribosomal protein mRNAs in human hepatocellular carcinoma. Anticancer Res 2001; 21(4A):2429-33; PMID:11724303.
14. Mduff FK, Hook CE, Tooze RM, Huntly BJ, Pandolfi PP, Turner SD. Determining the contribution of NPM1 heterozygosity to NPM-ALK-induced lymphomagenesis. Lab Invest 2011; 91:1298-303; PMID:21709672; http://dx.doi.org/10.1038/labinvest.2011.96.
15. Amsterdam A, Sadler KC, Lai K, Farrington S, Bronson RT, Lees JA, et al. Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol 2004; 2:E139; PMID:15138505; http://dx.doi.org/10.1371/journal.pbio.0020139.
16. Castro ME, Leal JF, Lleonart ME, Ramon Y Cajal S, Carnero A. Loss-of-function genetic screening identifies a cluster of ribosomal proteins regulating p53 function. Carcinogenesis 2008; 29:1343-50; PMID:18515283; http://dx.doi.org/10.1093/carcin/bgm302.
17. Deisenroth C, Zhang Y. Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway. Oncogene 2010; 29:4253-60; PMID:20498634; http://dx.doi.org/10.1038/onc.2010.189.
18. Ofir-Rosenfeld Y, Boggs K, Michael D, Kastan MB, Oren M. Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26. Mol Cell 2008; 32:180-9; PMID:18951086; http://dx.doi.org/10.1016/j.molcel. 2008.08.031.
19. Morgado-Palacin L, Llanos S, Serrano M. Ribosomal stress induces L11- and p53-dependent apoptosis in mouse pluripotent stem cells. Cell Cycle 2012; 11:503-10; PMID:22262176; http://dx.doi.org/10.4161/cc.11.3.19002.
20. Colombo E, Marine JC, Danovi D, Falini B, Pelicci PG. Nucleophosmin regulates the stability and transcriptional activity of p53. Nat Cell Biol 2002; 4:529-33; PMID:12080348; http://dx.doi.org/10.1038/ncb814.
21. Lo D, Lu H. Nucleostemin: Another nucleolar "Twister" of the p53-MDM2 loop. Cell Cycle 2010; 9:3227-32; PMID:20703089; http://dx.doi.org/10. 4161/cc.9.16.12605.
22. Wanzel M, Russ AC, Kleine-Kohlbrecher D, Colombo E, Pelicci PG, Eilers M. A ribosomal protein L23-nucleophosmin circuit coordinates Mizl function with cell growth. Nat Cell Biol 2008; 10:1051-61; PMID:19160485; http://dx.doi.org/ 10.1038/ncb1764.
23. Cuccurese M, Russo G, Russo A, Pietropaolo C. Alternative splicing and nonsense-mediated mRNA decay regulate mammalian ribosomal gene expression. Nucleic Acids Res 2005; 33:5965-77; PMID:16254077; http://dx.doi.org/10.1093/ nar/gki905.
24. Russo A, Catillo M, Esposito D, Briata P, Pietropaolo C, Russo G. Autoregulatory circuit of human rpL3 expression requires hnRNP H1, NPM and KHSRP. Nucleic Acids Res 2011; 39:7576-85; PMID:21705779; http://dx.doi.org/10. 1093/nar/gkr461.
25. Russo A, Siciliano G, Catillo M, Giangrande C, Amoresano A, Pucci P, et al. hnRNP H1 and intronic G runs in the splicing control of the human rpL3 gene. Biochim Biophys Acta 2010; 1799:419-28; PMID:20100605; http://dx.doi.org/10. 1016/j.bbagrm.2010.01.008.
26. Russo G, Cuccurese M, Monti G, Russo A, Amoresano A, Pucci P, et al. Ribosomal protein L7a binds RNA through two distinct RNA-binding domains. Biochem J 2005; 385:289-99; PMID:15361074; http://dx.doi.org/10.1042/BJ20040371.
27. Wu S, Cetinkaya C, Munoz-Alonso MJ, von der Lehr N, Bahram F, Beuger V, et al. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 2003; 22:351-60; PMID:12545156; http://dx.doi.org/10.1038/sj.onc.1206145.
28. Cen B, Deguchi A, Weinstein IB. Activation of protein kinase G Increases the expression of p21CIP1, p27KIP1, and histidine triad protein 1 through Sp1. Cancer Res 2008; 68:5355-62; PMID:18593937; http://dx.doi.org/10.1158/0008-5472. CAN-07-6869.
29. Huang L, Sowa Y, Sakai T, Pardee AB. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites. Oncogene 2000; 19:5712-9; PMID:11126357; http://dx.doi.org/10.1038/sj.onc.1203963.
30. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35:495-516; PMID:17562483; http://dx.doi.org/10.1080/01926230701320337.
31. Oliver FJ, de la Rubia G, Rolli V, Ruiz-Ruiz MC, de Murcia G, Murcia JM. Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem 1998; 273:33533-9; PMID:9837934; http://dx.doi.org/10.1074/jbc.273.50.33533.
32. Caldarola S, De Stefano MC, Amaldi F, Loreni F. Synthesis and function of ribosomal proteins - fading models and new perspectives. FEBS J 2009; 276:3199-210; PMID:19438715; http://dx.doi.org/10.1111/j.1742-4658.2009.07036.x.
33. Fromont-Racine M, Senger B, Saveanu C, Fasiolo F. Ribosome assembly in eukaryotes. Gene 2003; 313:17-42; PMID:12957375; http://dx.doi.org/10.1016/ S0378-1119(03)00629-2.
34. Kressler D, Hurt E, Bassler J. Driving ribosome assembly. Biochim Biophys Acta 2010; 1803:673-83; PMID:19879902; http://dx.doi.org/10.1016/j.bbamcr.2009. 10.009.
35. Lempiäinen H, Shore D. Growth control and ribosome biogenesis. Curr Opin Cell Biol 2009; 21:855-63; PMID:19796927; http://dx.doi.org/10.1016/j.ceb. 2009.09.002.
36. Miliani de Marval PL, Zhang Y. The RP-Mdm2-p53 pathway and tumorigenesis. Oncotarget 2011; 2:234-8; PMID:21406728.
37. Hölzel M, Burger K, Mühl B, Orban M, Kellner M, Eick D. The tumor suppressor p53 connects ribosome biogenesis to cell cycle control: a double-edged sword. Oncotarget 2010; 1:43-7; PMID:21293052.
38. Zhang Y, Lu H. Signaling to p53: ribosomal proteins find their way. Cancer Cell 2009; 16:369-77; PMID:19878869; http://dx.doi.org/10.1016/j.ccr. 2009.09.024.
39. Donati G, Montanaro L, Derenzini M. Ribosome biogenesis and control of cell proliferation: p53 is not alone. Cancer Res 2012; 72:1602-7; PMID:22282659; http://dx.doi.org/10.1158/0008-5472.CAN-11-3992.
40. Sherr CJ. Divorcing ARF and p53: an unsettled case. Nat Rev Cancer 2006; 6:663-73; PMID:16915296; http://dx.doi.org/10.1038/nrc1954.
41. Koutsodontis G, Tentes I, Papakosta P, Moustakas A, Kardassis D. Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein. J Biol Chem 2001; 276:29116-25; PMID:11384995; http://dx.doi.org/10.1074/jbc.M104130200.
42. Gartel AL. The conflicting roles of the cdk inhibitor p21(CIP1/WAF1) in apoptosis. Leuk Res 2005; 29:1237-8; PMID:15946739; http://dx.doi.org/10.1016/j. leukres.2005.04.023.
43. Chopin V, Toillon RA, Jouy N, Le Bourhis X. P21(WAF1/CIP1) is dispensable for G1 arrest, but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells. Oncogene 2004; 23:21-9; PMID:14712207; http://dx.doi.org/10.1038/sj.onc.1207020.
44. Hsu SL, Chen MC, Chou YH, Hwang GY, Yin SC. Induction of p21(CIP1/Waf1) and activation of p34(cdc2) involved in retinoic acid-induced apoptosis in human hepatoma Hep3B cells. Exp Cell Res 1999; 248:87-96; PMID:10094816; http://dx.doi.org/10.1006/excr.1999.4397.
45. Wu Q, Kirschmeier P, Hockenberry T, Yang TY, Brassard DL, Wang L, et al. Transcriptional regulation during p21WAF1/CIP1-induced apoptosis in human ovarian cancer cells. J Biol Chem 2002; 277:36329-37; PMID:12138103; http://dx.doi.org/10.1074/jbc.M204962200.
46. Pacifico F, Crescenzi E, Mellone S, Iannetti A, Porrino N, Liguoro D, et al. Nuclear factor-kappaB contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a. J Clin Endocrinol Metab 2010; 95:1421-30; PMID:20061417; http://dx.doi.org/10.1210/jc.2009-1128.
47. Iannetti A, Pacifico F, Acquaviva R, Lavorgna A, Crescenzi E, Vascotto C, et al. The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc Natl Acad Sci USA 2008; 105:14058-63; PMID:18768801; http://dx.doi.org/10. 1073/pnas.0710846105.